Shire Regenerative Medicine, Inc.
2 clinical trials · Sponsor
◉ Watch Shire Regenerative Medicine, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing (NCT01749306) | Shire Regenerative Medicine, Inc. | 2012-12-01 |
| Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers (NCT01891760) | Shire Regenerative Medicine, Inc. | 2010-05-01 |
Track Shire Regenerative Medicine, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.